Grant & Eisenhofer P.A.

Grant & Eisenhofer is one of the most successful plaintiff advocacy firms in the country. With extensive trial skills, G&E has successfully litigated numerous individual claims in state, federal and appellate courts. Our experienced attorneys are investigating vision loss claims due to Elmiron. Contact us by submitting the form or by calling us at (866) 575-7435 for a confidential evaluation of your potential claim.

Elmiron Manufacturer Updates U.S. Drug Label to Warn of Potential Eye Damage

As litigation against Janssen Pharmaceuticals, manufacturer of bladder pain drug Elmiron, mounts, the FDA has approved a change in the drug’s labeling in the U.S. The label of the drug’s “Warnings” section previously did not list any risks concerning visual impairment; however, labeling must now contain “Retinal Pigmentary Changes.” These changes may manifest as pigmentary …. Read More

Comments Off on Elmiron Manufacturer Updates U.S. Drug Label to Warn of Potential Eye Damage

Lawsuit Alleges Vision Injury, Pigmentary Maculopathy Due to Elmiron Use

In one of the first cases concerning eye damage related to drug Elmiron, the complaint filed in New Jersey Superior Court alleges failure to warn of the drug’s side effects. Elmiron is a prescription drug widely used to treat a bladder pain condition known as interstitial cystitis. Concerns relating to potentially permanent vision loss and …. Read More

Comments Off on Lawsuit Alleges Vision Injury, Pigmentary Maculopathy Due to Elmiron Use